Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


25.03.2019

1 BMC Neurosci
1 Brain
1 Exp Gerontol
8 J Alzheimers Dis
2 J Am Geriatr Soc
1 J Biol Chem
1 J Clin Psychiatry
1 J Neurosci
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurobiol Dis
1 Neuropsychology
2 Neurosci Lett
1 Neuroscience
1 PLoS One
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurosci

  1. SAKAKIBARA Y, Sekiya M, Saito T, Saido TC, et al
    Amyloid-beta plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    BMC Neurosci. 2019;20:13.
    PubMed     Text format     Abstract available


    Brain

  2. VOGLEIN J, Paumier K, Jucker M, Preische O, et al
    Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
    Brain. 2019 Mar 20. pii: 5416202. doi: 10.1093.
    PubMed     Text format     Abstract available


    Exp Gerontol

  3. KUGA GK, Munoz VR, Gaspar RC, Nakandakari SCBR, et al
    Impaired insulin signaling and spatial learning in middle-aged rats: The role of PTP1B.
    Exp Gerontol. 2018;104:66-71.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  4. GULISANO W, Maugeri D, Baltrons MA, Fa M, et al
    Role of Amyloid-beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
    J Alzheimers Dis. 2019;68:415.
    PubMed     Text format    

  5. HOLLINGER KR, Alt J, Rais R, Kaplin AI, et al
    The NAAG'ing Concerns of Modeling Human Alzheimer's Disease in Mice.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181251. doi: 10.3233/JAD-181251.
    PubMed     Text format     Abstract available

  6. HACKNEY ME, McCullough LE, Bay AA, Silverstein HA, et al
    Rationale and Design of a Clinical Trial of Adapted Tango to Improve Negative Health Impacts in Middle Aged African-American Female Caregivers of Persons with Alzheimer's Disease (ACT Trial).
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181130. doi: 10.3233/JAD-181130.
    PubMed     Text format     Abstract available

  7. STRUNZ M, Jarrell JT, Cohen DS, Rosin ER, et al
    Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181032. doi: 10.3233/JAD-181032.
    PubMed     Text format     Abstract available

  8. NGABIRANO L, Samieri C, Feart C, Gabelle A, et al
    Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180919. doi: 10.3233/JAD-180919.
    PubMed     Text format     Abstract available

  9. PARONI G, Bisceglia P, Seripa D
    Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180802. doi: 10.3233/JAD-180802.
    PubMed     Text format     Abstract available

  10. GROUSSARD M, Chan TG, Coppalle R, Platel H, et al
    Preservation of Musical Memory Throughout the Progression of Alzheimer's Disease? Toward a Reconciliation of Theoretical, Clinical, and Neuroimaging Evidence.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180474. doi: 10.3233/JAD-180474.
    PubMed     Text format     Abstract available

  11. MANCA C, Hopes L, Kearney-Schwartz A, Roch V, et al
    Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer's Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181146. doi: 10.3233/JAD-181146.
    PubMed     Text format     Abstract available


    J Am Geriatr Soc

  12. NAHARCI MI, Tasci I
    Comment on: Serum Cholesterol and Incident Alzheimer Disease: Findings From the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2019 Mar 20. doi: 10.1111/jgs.15877.
    PubMed     Text format    

  13. MARCUM ZA, Walker R, Bobb JF, Sin MK, et al
    Reply to: Comment on: Serum Cholesterol and Incident Alzheimer's Disease: Findings From the Adult Changes in Thought Study.
    J Am Geriatr Soc. 2019 Mar 20. doi: 10.1111/jgs.15879.
    PubMed     Text format    


    J Biol Chem

  14. WEISMILLER HA, Murphy R, Wei G, Ma B, et al
    Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
    J Biol Chem. 2018;293:17336-17348.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  15. GOLDFARB D, Sheard S, Shaughnessy L, Atri A, et al
    Disclosure of Alzheimer's Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication.
    J Clin Psychiatry. 2019;80.
    PubMed     Text format     Abstract available


    J Neurosci

  16. VIANA DA SILVA S, Zhang P, Georg Haberl M, Labrousse V, et al
    Hippocampal mossy fibers synapses in CA3 pyramidal cells are altered at an early stage in a mouse model of Alzheimer's disease.
    J Neurosci. 2019 Mar 18. pii: JNEUROSCI.2868-18.2019.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  17. FYFE I
    Alzheimer disease mice improve with CRISPR-Cas9 gene editing.
    Nat Rev Neurol. 2019 Mar 20. pii: 10.1038/s41582-019-0172.
    PubMed     Text format    


    Neurobiol Aging

  18. KENT BA, Michalik M, Marchant EG, Yau KW, et al
    Delayed daily activity and reduced NREM slow-wave power in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Neurobiol Aging. 2019;78:74-86.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  19. ADLIMOGHADDAM A, Snow WM, Stortz G, Perez C, et al
    Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease.
    Neurobiol Dis. 2019;127:264-277.
    PubMed     Text format     Abstract available


    Neuropsychology

  20. EL HAJ M, Gallouj K, Antoine P
    Mental imagery and autobiographical memory in Alzheimer's disease.
    Neuropsychology. 2019 Mar 21. pii: 2019-15654-001. doi: 10.1037/neu0000521.
    PubMed     Text format     Abstract available


    Neurosci Lett

  21. CAO J, Zhong MB, Toro CA, Zhang L, et al
    Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.
    Neurosci Lett. 2019 Mar 16. pii: S0304-3940(19)30171.
    PubMed     Text format     Abstract available

  22. NAKAYAMA Y, Sakamoto S, Tsuji K, Ayaki T, et al
    Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer's disease.
    Neurosci Lett. 2019 Mar 15. pii: S0304-3940(19)30175.
    PubMed     Text format     Abstract available


    Neuroscience

  23. ELFAKHRI KH, Duong QV, Langley C, Depaula A, et al
    Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-beta Clearance: In Vitro and In Vivo Studies.
    Neuroscience. 2018;379:269-280.
    PubMed     Text format     Abstract available


    PLoS One

  24. PERETTI DE, Vallez Garcia D, Reesink FE, van der Goot T, et al
    Correction: Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies.
    PLoS One. 2019;14:e0214187.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  25. HORTI AG, Naik R, Foss CA, Minn I, et al
    PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).
    Proc Natl Acad Sci U S A. 2019 Jan 11. pii: 1812155116.
    PubMed     Text format     Abstract available

  26. WU S, Song W, Wong CCL, Shi Y, et al
    Bax inhibitor 1 is a gamma-secretase-independent presenilin-binding protein.
    Proc Natl Acad Sci U S A. 2019;116:141-147.
    PubMed     Text format     Abstract available

  27. FICHOU Y, Lin Y, Rauch JN, Vigers M, et al
    Cofactors are essential constituents of stable and seeding-active tau fibrils.
    Proc Natl Acad Sci U S A. 2018;115:13234-13239.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: